Amelioration of hemophilia B through CRISPR/Cas9 induced homology-independent targeted integration
X. Chen, X. Niu, Y. Liu…·D. Li
This study uses CRISPR/Cas9 to induce homology-independent targeted integration in a rat hemophilia B model, achieving therapeutic correction with 3.66% knock-in efficiency and normalization of clotting time.